Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.99 - $1.46 $1,511 - $2,229
1,527 Added 40.28%
5,318 $5,000
Q4 2023

Feb 13, 2024

BUY
$0.6 - $2.18 $1,368 - $4,970
2,280 Added 150.89%
3,791 $4,000
Q3 2023

Nov 14, 2023

SELL
$1.72 - $2.45 $3,061 - $4,361
-1,780 Reduced 54.09%
1,511 $2,000
Q2 2023

Aug 14, 2023

SELL
$1.89 - $2.92 $578 - $893
-306 Reduced 8.51%
3,291 $6,000
Q1 2023

May 09, 2023

SELL
$2.2 - $3.4 $3,187 - $4,926
-1,449 Reduced 28.72%
3,597 $10,000
Q4 2022

Feb 10, 2023

BUY
$1.85 - $2.69 $1,515 - $2,203
819 Added 19.38%
5,046 $10,000
Q3 2022

Nov 10, 2022

BUY
$0.28 - $2.89 $683 - $7,054
2,441 Added 136.67%
4,227 $8,000
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.63 $2,173 - $4,397
1,672 Added 1466.67%
1,786 $3,000
Q1 2022

May 12, 2022

BUY
$1.25 - $3.97 $142 - $452
114 New
114 $0
Q4 2021

Feb 14, 2022

SELL
$2.4 - $5.01 $561 - $1,172
-234 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.62 - $9.25 $613 - $2,164
234 New
234 $1,000

About PetVivo Holdings, Inc.


  • Ticker PETV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,072,000
  • Market Cap $5.34M
  • Description
  • PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...
More about PETV
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.